Zuplenz FDA Approval
Links shared publicly online about this topic
FDA Approves Strativa Pharmaceuticals' Zuplenz (ondansetron) Oral Soluble Film
drugs.com — “Zuplenz (ondansetron) is used to prevent chemotherapy-induced, radiotherapy-induced, and postoperative nausea and vomiting. Includes Zuplenz side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 7, 2010 at 9:12 am By:
FDA Approves Strativa Pharmaceuticals' Zuplenz (ondansetron) Oral Soluble Film - http://bit.ly/c0E35U
Zuplenz oral soluble film approved for nausea and vomiting - MPR
empr.com — “The FDA has approved Zuplenz (ondansetron oral soluble film, from Strativa) for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting.” View full resource at empr.com
Most Recently Shared on July 6, 2010 at 3:33 pm By:
MPR News: Zuplenz oral soluble film approved for nausea and vomiting: The FDA has approved Zuplenz (ondansetron or... http://bit.ly/aXywsA
Strativa receives FDA approval for Zuplenz oral soluble film
news-medical.net — “Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.” View full resource at news-medical.net
Most Recently Shared on July 3, 2010 at 5:03 am By:
Strativa receives FDA approval for Zuplenz oral soluble film: Strativa Pharmaceuticals today announced that the U.... http://bit.ly/94H7c7
MonoSol Rx Announces FDA Approval Of Zuplenz(R) Oral Soluble Film For Treatment Of Nausea And Vomiting
medicalnewstoday.com — “MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, in collaboration with APR Applied Pharma Research s.a. of Switzerl” View full resource at medicalnewstoday.com
Most Recently Shared on July 9, 2010 at 2:05 pm By:
MNT Drug Approvals Health News
MonoSol Rx Announces FDA Approval Of Zuplenz(R) Oral Soluble Film For Treatment Of Nausea And Vomiting http://mnt.to/3FSS #regulatory
New Brain Cancer Treatment Approved By FDA
huffingtonpost.com — “WASHINGTON -- Device maker Novocure said Friday the Food and Drug Administration approved its first-of-a-kind treatment which fights cancerous brain tumors using electrical energy fields. The FDA approved the device for patients with aggressive brain tumors that have returned after treatment with chemotherapy and other interventions.” View full resource at huffingtonpost.com
Most Recently Shared on April 17, 2011 at 9:37 pm By:
ROMILA MUSHTAQ, M.D. Doctor, Neurologist, and Physician
FDA Approves Possible Chemotherapy Alternative For Brain Cancer http://huff.to/fKY7B9
FDA approves Erbitux to treat late-stage head and neck cancer
fda.gov — “The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.” View full resource at fda.gov
Most Recently Shared on November 7, 2011 at 7:27 pm By:
NCI Cancer Bulletin Health News
FDA approves Erbitux, in combination w/ chemotherapy, to treat late-stage head & neck cancer (release) http://t.co/bMtFRAyA
FDA approves Jevtana to treat men with prostate cancer
news-medical.net — “The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the first treatment for advanced, hormone-refractory, prostate cancer that has worsened during or after treatment with docetaxel, a commonly used drug for advanced prostate cancer.” View full resource at news-medical.net
Most Recently Shared on June 18, 2010 at 4:35 am By:
FDA approves Jevtana to treat men with prostate cancer: The U.S. Food and Drug Administration today approved Jevta... http://bit.ly/9YV2yC
Medical News: FDA Approves REMS for Drugs That Combat Anemia - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has announced a formal strategy to reduce the risks of erythropoiesis-stimulating agents (ESAs) for cancer patients who take the drugs to treat anemia caused by chemotherapy.” View full resource at medpagetoday.com
Most Recently Shared on February 16, 2010 at 10:41 pm By:
FDA Approves REMS for Drugs That Combat Anemia http://bit.ly/bL9xV5
Heat Treatment With Chemotherapy Kills Large Tumors; Approved By FDA; Next Stage Clinical Trials Start This Year At OUHSC
medicalnewstoday.com — “A new treatment developed and tested by university of oklahoma researchers not only killed large cancer tumors, but reduced the need for mastectomies by almost 90 percent. the latest results appea” View full resource at medicalnewstoday.com
Most Recently Shared on January 20, 2010 at 1:16 pm By:
Heat Treatment With Chemotherapy Kills Large Tumors; Approved By FDA; Next Stage Clinical Trials Start This Year At OUHSC http://mnt.to/3ww7
FDA Approves Cetuximab for Metastatic Head and Neck Cancer | Oral Cancer News
oralcancernews.org — “FDA Approves Cetuximab for Metastatic Head and Neck Cancer | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on November 8, 2011 at 2:00 pm By:
US FDA approval for expanded use of Erbitux | Oral Cancer News
oralcancernews.org — “US FDA approval for expanded use of Erbitux | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on November 9, 2011 at 8:24 am By:
FDA approves Sagent Pharmaceuticals' mesna injection for hemorrhagic cystitis
news-medical.net — “Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.” View full resource at news-medical.net
Most Recently Shared on April 19, 2010 at 1:35 pm By:
FDA approves Sagent Pharmaceuticals' mesna injection for hemorrhagic cystitis: Sagent Pharmaceuticals, Inc., a pri... http://bit.ly/dlkfZu
FDA approves breakthrough cancer therapy Provenge on Yahoo! Health
health.yahoo.com — “AP - A first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease received federal approval Thursday, offering an important alternative to more taxing treatments like chemotherapy.” View full resource at health.yahoo.com
Most Recently Shared on May 1, 2010 at 12:15 am By:
Steve Jorgenson Health Executive
FDA approves breakthrough cancer therapy Provenge http://ht.ly/1FgsU
INS cites FDA-approved Totect antidote for anthracycline extravasations
news-medical.net — “The third edition of Infusion Nursing: An Evidence-Based Approach, published by the Infusion Nurses Society (INS), includes Totect(®), the only FDA-approved treatment for anthracycline extravasation. Anthracyclines are a group of chemotherapy medications including daunorubicin, doxorubicin, idarubicin and epirubicin that have been used in the treatment of various types of cancer since the early 1970s.” View full resource at news-medical.net
Most Recently Shared on December 15, 2009 at 6:59 pm By:
Pregnancy News: INS cites FDA-approved Totect antidote for anthracycline extravasations: The third edition of Infus... http://bit.ly/6noU90
FDA Approves Elitek (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
drugs.com — “Elitek (rasburicase) is used to treat Hyperuricemia Secondary to Chemotherapy. Includes Elitek side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 19, 2009 at 11:24 pm By:
FDA Approves Elitek (rasburicase) for Management of Hyperuricemia in Adults Receiving Chemotherapy - http://bit.ly/3ifMlA
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
News-Medical.Net
Medical News from Around the World
Advertisement
